GB201811143D0 - Mangiferin-containing skin-care compositions and methods - Google Patents

Mangiferin-containing skin-care compositions and methods

Info

Publication number
GB201811143D0
GB201811143D0 GBGB1811143.5A GB201811143A GB201811143D0 GB 201811143 D0 GB201811143 D0 GB 201811143D0 GB 201811143 A GB201811143 A GB 201811143A GB 201811143 D0 GB201811143 D0 GB 201811143D0
Authority
GB
United Kingdom
Prior art keywords
mangiferin
methods
care compositions
containing skin
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1811143.5A
Other versions
GB2576301A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB1811143.5A priority Critical patent/GB2576301A/en
Publication of GB201811143D0 publication Critical patent/GB201811143D0/en
Priority to PCT/GB2019/050234 priority patent/WO2019150087A1/en
Priority to US16/965,022 priority patent/US20210106601A1/en
Priority to EP19707445.3A priority patent/EP3746127A1/en
Publication of GB2576301A publication Critical patent/GB2576301A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
GB1811143.5A 2018-01-30 2018-07-06 Mangiferin-containing skin-care compositions and methods Withdrawn GB2576301A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB1811143.5A GB2576301A (en) 2018-07-06 2018-07-06 Mangiferin-containing skin-care compositions and methods
PCT/GB2019/050234 WO2019150087A1 (en) 2018-01-30 2019-01-29 Mangiferin as a protective agent against mitochondrial dna damage and skin-care compositions comprising same
US16/965,022 US20210106601A1 (en) 2018-01-30 2019-01-29 Mangiferin as a protective agent against mitochondrial dna damage and skin-care compositions comprising same
EP19707445.3A EP3746127A1 (en) 2018-01-30 2019-01-29 Mangiferin as a protective agent against mitochondrial dna damage and skin-care compositions comprising same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1811143.5A GB2576301A (en) 2018-07-06 2018-07-06 Mangiferin-containing skin-care compositions and methods

Publications (2)

Publication Number Publication Date
GB201811143D0 true GB201811143D0 (en) 2018-08-22
GB2576301A GB2576301A (en) 2020-02-19

Family

ID=63170780

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1811143.5A Withdrawn GB2576301A (en) 2018-01-30 2018-07-06 Mangiferin-containing skin-care compositions and methods

Country Status (1)

Country Link
GB (1) GB2576301A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111803421A (en) * 2020-08-13 2020-10-23 苏格格 Moisturizing, whitening and skin-care cream

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE206611T1 (en) * 1994-11-25 2001-10-15 Rocher Yves Biolog Vegetale USE OF MANGIFERIN OR ITS DERIVATIVES FOR COSMETIC USE
CN1977855A (en) * 2005-12-09 2007-06-13 海南盛科天然药物研究院有限公司 Medicinal composition containing mangiferin and its preparing method
CN101019877A (en) * 2007-03-22 2007-08-22 广西中医学院 Soluble mangiferin clathrate and its prepn
FR2929945B1 (en) * 2008-04-11 2010-09-03 Inst Rech Developpement Ird PROCESS FOR EXTRACTING MANGIFERIN AND ISOMANFIGERIN
CN103462975A (en) * 2013-09-24 2013-12-25 昆明理工大学 Inclusion compound of mangiferin and alkaline cyclodextrin
US20210106601A1 (en) * 2018-01-30 2021-04-15 Olusola Clement Idowu Mangiferin as a protective agent against mitochondrial dna damage and skin-care compositions comprising same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111803421A (en) * 2020-08-13 2020-10-23 苏格格 Moisturizing, whitening and skin-care cream

Also Published As

Publication number Publication date
GB2576301A (en) 2020-02-19

Similar Documents

Publication Publication Date Title
IL279897A (en) Fusosome compositions and uses thereof
SG11202011015QA (en) Fusosome compositions and uses thereof
IL280134A (en) Anti-cd112r compositions and methods
IL268970A (en) Novel compositions and methods
HUE065174T2 (en) Hla-based methods and compositions and uses thereof
GB201807325D0 (en) Compositions and methods
GB202201861D0 (en) Novel methods and compositions
IL279755A (en) Senolytic compositions and uses thereof
SG11202104448WA (en) Compositions and methods
GB201819987D0 (en) Methods and compositions
GB201817444D0 (en) Methods and compositions
IL277663A (en) Erenumab compositions and uses thereof
ZA202004533B (en) Skin-brightening compositions and methods
GB201807576D0 (en) Compositions and uses thereof
GB201811143D0 (en) Mangiferin-containing skin-care compositions and methods
GB201821138D0 (en) Compositions and uses thereof
GB201812334D0 (en) Compositions and uses thereof
IL290531A (en) Skin-care compositions and uses thereof
GB201817902D0 (en) Methods and compositions
GB201821144D0 (en) Compositions and uses thereof
GB201819493D0 (en) Compositions and uses thereof
GB201809880D0 (en) Compositions and methods
GB201818495D0 (en) Compositions and uses thereof
GB201818375D0 (en) Compositions and uses thereof
GB201804092D0 (en) Methods and compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)